- $37.67m
- -$70.63m
- 21
- 52
- 57
- 39
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.35 | 22.4 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 43.8 | 63.6 | 70.8 | 75.9 | 67.6 |
Operating Profit | -37.5 | -41.2 | -70.8 | -75.9 | -67.6 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -33.7 | -36.6 | -69.4 | -74.7 | -62.7 |
Net Income After Taxes | -33.7 | -36.6 | -69.4 | -74.7 | -62.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -33.7 | -36.6 | -69.4 | -74.7 | -62.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -33.7 | -36.6 | -69.4 | -74.7 | -62.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.15 | -1.33 | -2.51 | -2.69 | -2.25 |